Molecular mechanisms of prostate cancer cell death triggered by inhibition of arachidonate 5-lipoxygenase: Involvement of Fas death receptor-mediated signals

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 415-420

  Ghosh, Jagadananda ^a   Myers, Charles E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ANTIANDROGEN; ANTINEOPLASTIC AGENT; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CYTOCHROME P450; FAS ANTIGEN; HORMONE; LYMPHOCYTE ANTIGEN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ENZYME INHIBITOR;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; DNA DEGRADATION; HUMAN; METASTASIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TREATMENT FAILURE; ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ANTIGENS, CD95; ARACHIDONATE 5-LIPOXYGENASE; CELL DEATH; ENZYME INHIBITORS; HUMANS; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0038237439     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_64     Document Type: Conference Paper

References (26)

1. tSteel, G. G. (1977) In Growth Kinetics of Tumors, Oxford University Press, Oxford.
2. Steller, H. Mechanisms and genes of cellular suicide. Science (Washington DC), 267:1445-1449 (1995).
3. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics, 1997. CA Cancer J. Clin. 47:5-27 (1997).
4. Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, A., Blumenstein, B. A., Davis, M. A., and Goodman, P. J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N. Eng. J. Med. 321:419-424 (1989).
5. Ghosh, J., and Myers, C. EArachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun. 235:418-423 (1997).
6. Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. W., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., Teh, C., and Paffenbarger, R. S. Prostate cancer in relation to diet, physical activity and body size, in blacks, whites and asians in the U. S. and Canada. J. Natl. Cancer Inst. 87:652-661 (1995).
7. Mettlin, C., Selenskas, S., Natarajan, N., and Huben, R. Beta-carotene and animal fats and their relationship to prostate cancer risk. Cancer 64:605-612 (1989).
8. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., and Willett, W. C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1571-1579 (1993).
9. Le Marchand, L., Kolonel, L. N., Wilkins, L. R., Myers, B. C., and Hirohata, T. Animal fat consumption and cancer of the prostate: a prospective study in Howaii. Epidemiology 5:276-282 (1994).
10. Gann, P. H., Hennekens, C. H., Sacks, F. M., Grodstein, F., Giovannucci, E., and Stampfer, M. J. Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl. Cancer Inst. 86:281-286 (1994).
11. Wang, Y., Corr, J. G., Thaler, H. T., Tao, Y., Fair, W. R., and Heston, W. D. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Cancer Inst. 87:1456-1462 (1995).
12. Han, J., McCormick, F., and Macara, I. G. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Science (Washington DC) 252:576-579 (1991).
13. Khan, W. A., Blobe, G. C., and Hannun, Y. A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell, Signaling 7:171-184 (1995).
14. Schachter, J. B., Lester, D. S., and Alkon, D. L. Synergistic activation of protein kinase C by arachidonic acid and diacylglycerol in vitro: generation of a stable membrane-bound, cofactor-independent state of protein kinase C activity. Biochim. Biophys. Acta 1291:167-176(1996).
15. Ara, G., and Teicher, B. A. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins, Leukotrienes and Essential Fatty Acids 54:3-16 (1996).
16. Young, M. R. Eicosanoids and the immunology of cancer. Cancer Met. Rev. 13: 337-348 (1994).
17. Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., and Dey, S. K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208 (1997).
18. + T lymphoblasts. J. Immunol. 154:1041-1047 (1995).
19. Ghosh, J., and Myers, C. E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. USA 95:13182 13187 (1998).
20. Ghosh, J., and Myers, C. E. Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells. Adv. Exp. Med. Biol. 469:577-582 (1999).
21. 21.Rokhlin, O. W., Bishop, G. A., Hostager, B. S., Waldschmidt, T. J., Sidorenko, S. P., Pavloff, N., Kiefer, M. C., Umansky, S. R., Glover, R. A., and Cohen, M. B. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 57:1758-1768 (1997).
22. Hedlund, T. E., Duke, R. C., Schleicher, M. S., and Miller, G. J. Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36:92-101 (1998).
23. Frost, P. J., Ng, C. P., Belldegrun, A., and Bonavida, B. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-FasL pathway of cytotoxicity. Cell. Immunol. 180:70-83 (1997).
24. Uslu, R., Borsellino, N., Frost, P. J., Garban, H., Ng, C. P., Mizutani, Y., Belldegrun, A., and Bonavida, B. Chemosensitization of human prostate carcinoma cell lines to anti-Fas-mediated cytotoxicity and apoptosis. Clin. Cancer Res. 3:963-972 (1997).
25. Liu, Q. Y., Rubin, M. A., Omene, C., Lederman, S., and Stein, C. A. Fas ligand is constitutively secreted by prostate cancer cells in vitro. Clin. Cancer Res. 4:1803-1811 (1998).
26. Chinnaiyan, A. M. The apoptosome: heart and soul of the cell death machine. Neoplasia 1:5-15 (1999).